BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/20/2026 9:06:33 AM | Browse: 98 | Download: 628
Publication Name World Journal of Clinical Oncology
Manuscript ID 112801
Country Egypt
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medicine, General & Internal
Manuscript Type Case Control Study
Article Title Prognostic significance of PD-L1/PD-1 co-expression and CXCR3-driven inflammatory signatures in Egyptian patients with lymphoproliferative neoplasms
Manuscript Source Invited Manuscript
All Author List Dalia E Sherief, Nahla Nosair, Aya Mohammed Abdelhameed, Emad Sadaka, Amira A A Othman and Rasha Elgamal
ORCID
Author(s) ORCID Number
Amira A A Othman http://orcid.org/0000-0002-8191-0035
Funding Agency and Grant Number
Corresponding Author Amira A A Othman, Chief Physician, MD, PhD, Professor, Department of Internal Medicine, Faculty of Medicine, Suez University, Suez 43511, As Suways, Egypt. amira.othman@med.suezuni.edu.eg
Key Words Lymphoproliferative neoplasms; Programmed death ligand-1; Programmed death 1; C-X-C motif chemokine receptor 3; Systemic immune-inflammation index; Systemic inflammation response index; Inflammatory biomarkers
Core Tip This case-control study explores the prognostic value of programmed death ligand-1/programmed death 1 co-expression and C-X-C motif chemokine receptor (CXCR) 3-driven immune signatures in Egyptian patients with lymphoproliferative neoplasms. By integrating flow cytometric analysis with systemic inflammation indices - systemic immune-inflammation index and systemic inflammation response index - the study identifies novel biomarker panels predictive of disease stage, recurrence, and survival. Findings support the use of programmed death ligand-1/CXCR3 and programmed death 1/CXCR3 as clinically relevant tools for risk stratification in resource-limited settings, paving the way for personalized management of lymphoproliferative neoplasms.
Publish Date 2026-01-20 09:06
Citation

Sherief DE, Nosair N, Abdelhameed AM, Sadaka E, Othman AAA, Elgamal R. Prognostic significance of PD-L1/PD-1 co-expression and CXCR3-driven inflammatory signatures in Egyptian patients with lymphoproliferative neoplasms. World J Clin Oncol 2026; 17(1): 112801

URL https://www.wjgnet.com/2218-4333/full/v17/i1/112801.htm
DOI https://dx.doi.org/10.5306/wjco.v17.i1.112801
Full Article (PDF) WJCO-17-112801-with-cover.pdf